NCT04629807 is a NA clinical trial of Anterior Lumbar Interbody Fusion (ALIF) in Spine Fusion, sponsored by SeaSpine, Inc..

Who is sponsoring NCT04629807?

NCT04629807 is sponsored by SeaSpine, Inc..

What drugs are being tested in NCT04629807?

Interventions in NCT04629807: Anterior Lumbar Interbody Fusion (ALIF).

What condition does NCT04629807 study?

NCT04629807 studies Spine Fusion.

Is NCT04629807 still recruiting?

NCT04629807 is currently status unknown. Last updated 4 April 2023.

Last reviewed 2023-04-04 · How we verify

NCT04629807

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anterior Gen Plus Study

Status unknown NA Last updated 4 April 2023

What this trial tests

NA trial testing Anterior Lumbar Interbody Fusion (ALIF) in Spine Fusion in 8 participants. Status unknown.

Timeline

15 September 2020

Primary endpoint
16 December 2022

30 April 2023

Quick facts

Lead sponsor	SeaSpine, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	8
Start date	15 September 2020
Primary completion	16 December 2022
Estimated completion	30 April 2023
Sites	1 location across United States

Drugs / interventions tested

Anterior Lumbar Interbody Fusion (ALIF)

Conditions studied

Spine Fusion — all drugs for Spine Fusion →

Sponsor

SeaSpine, Inc.

Who can join

18 and older, any sex, with Spine Fusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A clinical study evaluating patients treated with the Demineralized Bone Matrix (DBM) as compared to a Cellular Bone Matrix (CBM) in anterior lumbar interbody fusion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Allografts and Spinal Fusion.
Cohen JD, Kanim LE, Tronits AJ, Bae HW. · · 2021 · cited 14× · PMID 34376497 · DOI 10.14444/8056

Verify or expand the search:

Other recruiting trials for Spine Fusion

Currently open trials in the same condition.

NCT06975072 — Effect of Magnesium on Neuromonitoring · Phase 4 · recruiting
NCT04679844 — Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Au · NA · recruiting
NCT05957822 — Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery · Phase 4 · recruiting
NCT06140927 — Effect of Ketamine on Intraoperative Motor Evoked Potentials · Phase 3 · recruiting
NCT05367609 — Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB) · NA · recruiting

Other SeaSpine, Inc. trials

Trials by the same sponsor.

NCT04300777 — The Fixation Study · unknown
NCT04629794 — The OsteoStrand Plus Deformity Study · NA · unknown
NCT03871400 — The NanoStrand Clinical Study · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04629807 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by SeaSpine, Inc.
Last refreshed: 4 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04629807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing